Hometa

Did you know that Eli Lilly and Company’s new monoclonal antibody COVID treatment, Bamlanivimab/Etesevimab, can be administered via gravity infusion? DripAssist can provide support for clinicians and nurses administering such infusion treatments. #COVID19 #covidtreatment

In Phase II trials, Eli Lilly and Company and GSK's combo bamlanivimab and VIR-7831 successfully reduced viral loads of Covid-19 with mild to moderate symptom patients; seeing a 70% greater reduction than the placebo patients.

Eli Lilly and Company and AbCellera have been identified a new monoclonal antibody (mAb) currently in preclinical trials that is predicted to neutralize all circulating COVID variants https://conta.cc/3t3tGia

Three existing FDA-approved drugs; Pfizer’s lung cancer drug Vizimpro (dacomitinib), the antibiotic salinomycin and cyclosporine, have shown capabilities of inhibiting COVID-19 virus in respiratory cells. https://conta.cc/3umKcK9

One of the three emergency-use COVID monoclonal antibody (mAb) treatments by Eli Lilly and Company features its Incyte-partnered drug Olumiant, in combination with Gilead Sciences’s remdesivir. #COVID19